Hujer AM - Search Results

1

Exploring the effectiveness of tazobactam against ceftazidime resistant Escherichia coli: insights from the comparison between susceptibility testing and beta-lactamase inhibition.

Bethel CR, Hujer AM, Helfand MS, Bonomo RA. Bethel CR, et al. Among authors: hujer am. FEMS Microbiol Lett. 2004 May 1;234(1):99-103. doi: 10.1016/j.femsle.2004.03.025. FEMS Microbiol Lett. 2004. PMID: 15109726

2

Structure of the SHV-1 beta-lactamase.

Kuzin AP, Nukaga M, Nukaga Y, Hujer AM, Bonomo RA, Knox JR. Kuzin AP, et al. Among authors: hujer am. Biochemistry. 1999 May 4;38(18):5720-7. doi: 10.1021/bi990136d. Biochemistry. 1999. PMID: 10231522

3

High-level expression of chromosomally encoded SHV-1 beta-lactamase and an outer membrane protein change confer resistance to ceftazidime and piperacillin-tazobactam in a clinical isolate of Klebsiella pneumoniae.

Rice LB, Carias LL, Hujer AM, Bonafede M, Hutton R, Hoyen C, Bonomo RA. Rice LB, et al. Among authors: hujer am. Antimicrob Agents Chemother. 2000 Feb;44(2):362-7. doi: 10.1128/AAC.44.2.362-367.2000. Antimicrob Agents Chemother. 2000. PMID: 10639363 Free PMC article.

4

Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients.

Donskey CJ, Chowdhry TK, Hecker MT, Hoyen CK, Hanrahan JA, Hujer AM, Hutton-Thomas RA, Whalen CC, Bonomo RA, Rice LB. Donskey CJ, et al. Among authors: hujer am. N Engl J Med. 2000 Dec 28;343(26):1925-32. doi: 10.1056/NEJM200012283432604. N Engl J Med. 2000. PMID: 11136263 Free PMC article.

5

Inhibition of the SHV-1 beta-lactamase by sulfones: crystallographic observation of two reaction intermediates with tazobactam.

Kuzin AP, Nukaga M, Nukaga Y, Hujer A, Bonomo RA, Knox JR. Kuzin AP, et al. Biochemistry. 2001 Feb 13;40(6):1861-6. doi: 10.1021/bi0022745. Biochemistry. 2001. PMID: 11327849

6

Mutagenesis of amino acid residues in the SHV-1 beta-lactamase: the premier role of Gly238Ser in penicillin and cephalosporin resistance.

Hujer AM, Hujer KM, Bonomo RA. Hujer AM, et al. Among authors: hujer km. Biochim Biophys Acta. 2001 May 5;1547(1):37-50. doi: 10.1016/s0167-4838(01)00164-9. Biochim Biophys Acta. 2001. PMID: 11343789

7

Inactivation of CMY-2 beta-lactamase by tazobactam: initial mass spectroscopic characterization.

Bonomo RA, Liu J, Chen Y, Ng L, Hujer AM, Anderson VE. Bonomo RA, et al. Among authors: hujer am. Biochim Biophys Acta. 2001 Jun 11;1547(2):196-205. doi: 10.1016/s0167-4838(01)00175-3. Biochim Biophys Acta. 2001. PMID: 11410275

8

Substitution of Thr for Ala-237 in TEM-17, TEM-12 and TEM-26: alterations in beta-lactam resistance conferred on Escherichia coli.

Giakkoupi P, Hujer AM, Miriagou V, Tzelepi E, Bonomo RA, Tzouvelekis LS. Giakkoupi P, et al. Among authors: hujer am. FEMS Microbiol Lett. 2001 Jul 10;201(1):37-40. doi: 10.1111/j.1574-6968.2001.tb10729.x. FEMS Microbiol Lett. 2001. PMID: 11445164

9

Development of a sensitive and specific enzyme-linked immunosorbent assay for detecting and quantifying CMY-2 and SHV beta-lactamases.

Hujer AM, Page MG, Helfand MS, Yeiser B, Bonomo RA. Hujer AM, et al. J Clin Microbiol. 2002 Jun;40(6):1947-57. doi: 10.1128/JCM.40.6.1947-1957.2002. J Clin Microbiol. 2002. PMID: 12037047 Free PMC article.

10

Broad resistance due to plasmid-mediated AmpC beta-lactamases in clinical isolates of Escherichia coli.

Odeh R, Kelkar S, Hujer AM, Bonomo RA, Schreckenberger PC, Quinn JP. Odeh R, et al. Among authors: hujer am. Clin Infect Dis. 2002 Jul 15;35(2):140-5. doi: 10.1086/340742. Epub 2002 Jun 24. Clin Infect Dis. 2002. PMID: 12087519

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters